Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Filings indexed 331 across all filing types
Latest filing 2019-01-28 Environmental & Social …
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Elos Medtech receives funds for dental surface project from Innovation Fund Denmark
Environmental & Social Information Classification · 99% confidence The document announces specific, non-financial news regarding a research project receiving funding from Innovation Fund Denmark and discusses the technical/aesthetic challenges in dental implants. It concludes with a statement that this information is the type the company is obliged to publish in accordance with the EU Market Abuse Regulation and the Swedish Securities Market Act, and it was issued for publication on a specific date and time. This structure strongly suggests a mandatory regulatory disclosure that is not a standard periodic report (10-K, IR, ER) or a specific corporate action (DIV, CAP, SHA). Since it is a general regulatory announcement concerning business operations and funding, and it doesn't fit the more specific categories like Director's Dealing (DIRS), M&A (TAR), or Dividend (DIV), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (3496 chars), but it is the substance of the announcement itself, not an announcement *about* another report, so RPA is less suitable than RNS for this type of market-sensitive news release.
2019-01-28 English
Elos Medtech överlåter verksamhet inom segmentet Hearing Device & Vibration
M&A Activity Classification · 99% confidence The document is a press release from Elos Medtech AB announcing the divestiture (överlåtelse) of its Hearing Device & Vibration business segment to Bruel&Kjaer. It details the strategic rationale, timeline (first half of 2019), and contact information. The final paragraph explicitly states that the information is 'such information that Elos Medtech AB (publ) is obliged to make public according to the EU Market Abuse Regulation' and was released on January 9, 2019. This structure strongly indicates a mandatory regulatory disclosure that is not a standard periodic report (like 10-K or IR) or a specific corporate action like a dividend or share buyback. Since it is a general regulatory announcement concerning a significant business event that doesn't fit the more specific categories (like M&A/TAR, which usually involves a formal bid or acquisition agreement), the most appropriate classification is the general regulatory filing fallback category.
2019-01-09 Swedish
Elos Medtech transfer business within the segment Hearing Device & Vibration
M&A Activity Classification · 99% confidence The document announces a specific business transaction: the transfer of business operations related to assembly and calibration of sound and vibration products from Elos Medtech to Bruel & Kjaer. This is a strategic corporate action involving a divestiture or transfer of a non-core segment, aligning with the company's stated focus on medical technology. This type of announcement, detailing a significant corporate transaction (like a merger, acquisition, or major asset transfer), best fits the 'M&A Activity' category (TAR). It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a financing event (CAP). Given the nature of the announcement, TAR is the most appropriate classification.
2019-01-09 English
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage and quantity for a specific instrument (B Shares SE0000120776) held by Nordea Funds Ltd in Elos Medtech AB. It explicitly mentions 'Reason for major shareholding notification Buy' and provides 'Before the transaction' and 'After the transaction' figures, including resulting percentages of voting rights. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing type code MRQ.
2018-12-19 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for Elos Medtech, covering the period of July-September 2018 and January-September 2018. It includes detailed financial statements, management commentary (VD-kommentar), segment reporting, and key performance indicators (Nyckeltal). It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, which fits the definition of an Interim/Quarterly Report (IR). Q3 2018
2018-10-25 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT 2018' and provides comprehensive financial data, including income statements, balance sheets, cash flow analysis, and segment reporting for the third quarter and the first nine months of 2018. It contains detailed management commentary and performance metrics, fitting the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-10-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.